Assistance Médicale à la Procréation et Risque Thrombotique
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Sponsor
- University Hospital, Brest
- Enrollment
- 129
- Locations
- 9
- Primary Endpoint
- Evaluation of professional clinical practice for ovarian stimulation care
Study Overview
Brief Summary
This study aims at evaluating clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation.
Secondary outcomes are : 1) to describe the incidence and risk factors of arterial and venous thrombosis in women undergoing assisted reproductive technology and 2)to identify the incidence and risk factors for ovarian hyperstimulation syndrome in these women
Detailed Description
All women undergoing an assisted reproductive tecnology in order to receive an in vitro fertilization in French centers will be included in the study. These women will be followed up until 12 months after ovarian stimulation if they get pregnant or until 3 months if the stimulation does not lead to pregnancy. Risk factors for thrombosis and ovarian hyperstimulation syndrome will be collected in each woman. At each visit, women will be asked whether arterial and/or venous thrombosis had occured.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •All women undergoing ovarian stimulation in order to receive in vitro fertilization
Exclusion Criteria
- •Age<18 years
- •Women refusing to particpate in the study
- •No health coverage
- •Women under guardianship
- •Women receiving therapeutic doses of anticoagulation
Outcomes
Primary Outcomes
Evaluation of professional clinical practice for ovarian stimulation care
Time Frame: Until 12 months followin ovarian stimulation
Secondary Outcomes
- Arterial and/or venous thrombosis(until 12 months following ovarian stimulation)
- Risk factors for thrombosis(until 12 months following ovarian stimulation)